MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
224<br />
The same leaflet also states: “Medical authorities are not certa<strong>in</strong> that CFS is exactly the same illness as <strong>ME</strong>,<br />
but until scientific evidence shows that they are different they have decided to treat CFS and <strong>ME</strong> as if they<br />
are one illness”.<br />
This is a seriously mislead<strong>in</strong>g statement, because the Wessely School do not dist<strong>in</strong>guish between the<br />
Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (<strong>ME</strong>) and chronic fatigue (CF) and they ignore<br />
the <strong>in</strong>ternational research show<strong>in</strong>g that <strong>ME</strong>/CFS (ICD‐10 G93.3) is not the same as “chronic fatigue” (ICD‐10<br />
F48.0). It seems that no matter how extensive the exist<strong>in</strong>g evidence, the Wessely School will cont<strong>in</strong>ue to<br />
dismiss and/or ignore it because it does not accord with their own agenda of eradicat<strong>in</strong>g <strong>ME</strong> and<br />
reclassify<strong>in</strong>g “CFS” (by which they mean medically unexpla<strong>in</strong>ed chronic “fatigue”) as a behavioural<br />
disorder.<br />
To comb<strong>in</strong>e different disorders ‐‐ a neurological disease (<strong>ME</strong> / ICD‐10 G93.3), a soft tissue disorder (FM /<br />
ICD‐10 M79) ) and a somatisation disorder (chronic “fatigue” / ICD‐10 F48.0) ‐‐ and then to regard and<br />
manage them as a s<strong>in</strong>gle psychiatric disorder is a cause for concern because <strong>in</strong>terventions that may be<br />
suitable for those with “chronic fatigue” may be harmful and even fatal for some with <strong>ME</strong>.<br />
That such a failure to differentiate between disparate disorders runs throughout the PACE Trial is shown by<br />
a job advertisement placed by the Oxford Radcliffe Hospitals NHS Trust (one of the PACE Trial<br />
participat<strong>in</strong>g Centres) for a Research Cognitive Behaviour Therapist, which said:<br />
“This is a unique opportunity to learn specialised treatment skills and to participate <strong>in</strong> a high profile Medical Research<br />
Council funded treatment for patients with chronic medically unexpla<strong>in</strong>ed fatigue (CFS/<strong>ME</strong>)”.<br />
<strong>ME</strong>/CFS is not “chronic medically unexpla<strong>in</strong>ed fatigue” but a classified nosological entity <strong>in</strong> which the<br />
pathognomonic feature is post‐exertional fatiguability, not “fatigue” which equates to “tiredness”.<br />
The nub of the problem lies <strong>in</strong> the criteria used to def<strong>in</strong>e “CFS/<strong>ME</strong>” <strong>in</strong> the PACE Trial, and <strong>in</strong>deed <strong>in</strong> all the<br />
trials concern<strong>in</strong>g behavioural <strong>in</strong>terventions for “CFS” published by the Wessely School to date. On 20 th May<br />
2009, a letter to the New Scientist from Jennifer Wilson summarised the problem:<br />
“In most studies <strong>in</strong>to the efficacy of cognitive behavioural therapy (CBT) and graded exercise therapy (GET), the people<br />
who report <strong>in</strong> favour of the treatments most likely do not have, nor ever had, <strong>ME</strong>. They are likely to be suffer<strong>in</strong>g from<br />
psychological chronic fatigue, which is very different. The <strong>in</strong>clusion of people with chronic fatigue <strong>in</strong> research <strong>in</strong>to <strong>ME</strong><br />
muddies the waters. <strong>ME</strong> sufferers cannot undertake exercise ‐ not even graded exercise ‐ without worsen<strong>in</strong>g their<br />
illness. Some of the criteria for <strong>in</strong>clud<strong>in</strong>g people <strong>in</strong> studies on CBT/GET exclude the very markers that show someone<br />
has <strong>ME</strong>, such as the very dist<strong>in</strong>ctive symptom of post‐exertional malaise. Reported success stories highlight not those<br />
with <strong>ME</strong>, but sufferers of the entirely different illness, chronic fatigue” (accessible at<br />
http://www.newscientist.com/article/mg20227090.500‐confused‐over‐me.html ).<br />
When the Wessely School refers to “evidence‐based medic<strong>in</strong>e” (EBM) <strong>in</strong> this context, they are referr<strong>in</strong>g to<br />
the reportedly positive f<strong>in</strong>d<strong>in</strong>gs <strong>in</strong> certa<strong>in</strong> controlled trials of cognitive behavioural therapy (CBT) and<br />
graded exercise therapy (GET) aimed at <strong>in</strong>creas<strong>in</strong>g a “CFS/<strong>ME</strong>” patient’s activity level. However, the<br />
recruitment criteria which they use to identify patients with “CFS/<strong>ME</strong>” are their own and are not used by<br />
most <strong>in</strong>ternational researchers: they are regarded as obsolete by medical scientists; they lack diagnostic<br />
specificity and select a heterogeneous patient population, thus their results lack mean<strong>in</strong>gful scientific<br />
<strong>in</strong>terpretation.<br />
As the Wessely School ignore all the cl<strong>in</strong>ical signs and much of the key symptomatology of <strong>ME</strong>/CFS,<br />
focus<strong>in</strong>g on subjective “fatigue”, their data‐set cannot be representative of <strong>ME</strong>/CFS patients, yet they<br />
repeatedly claim to <strong>in</strong>clude and study those who suffer from <strong>ME</strong> under their own umbrella of “medically<br />
unexpla<strong>in</strong>ed chronic fatigue”; however, they do not study people with other discrete neurological disorders